Dermatitis News

There is a significant association between postpartum depression and maternal depression and higher odds of childhood atopic dermatitis, according to a prospective cohort study published in Dermatitis.

Some 500 dermatologists will gather in Maui at the end of January for the sixth annual Maui Derm for Dermatologists meeting. If all goes as planned, they will leave the Hawaiian island with actionable strategies to put to immediate use in the clinic.

As 2019 draws to a close, Healio reflects on the top news in dermatology from not only the past year, but the past 10 years, as we welcome a new decade of discoveries and practice-changing approvals.

Observational evidence identified a potential association between atopic dermatitis and an increased risk for keratinocyte carcinoma and kidney cancer, as well as lower odds of lung and respiratory system cancers, according to a meta-analysis in JAMA Dermatology.

Upadacitinib reduced all clinical disease measures including itch-related outcomes at 16 weeks in patients with moderate to severe atopic dermatitis, according to phase 2b study results published in Journal of Allergy and Clinical Immunology.

Aa result of advocacy by the Skin of Color Society, more dermatologic professionals are committed to work that strives to improve the societal inequities of health care and advance the science in skin of color.

LEO Pharma announced that tralokinumab met all primary and secondary endpoints in ECZTRA 1-3, its three pivotal phase 3 studies for moderate to severe atopic dermatitis in adults.

Individuals in the U.S. with psoriasis are at an increased risk for developing migraines, according to a cross-sectional study.

In a top Healio Dermatology story, preliminary findings from Emma Guttman-Yassky, MD, PhD, demonstrate a novel use of dupilumab for managing chronic keloids with reductions in skin fibrosis and keloidal scarring, which may suggest a potential underlying Th2 pathogenesis in keloid formation.

Patients hospitalized for dermatologic issues with concomitant micronutrient deficiencies had a significantly increased length of stay and higher 30-day mortality rates, according to a study.